白云山(600332.SH)子公司药品通过仿制药一致性评价

Core Viewpoint - The company Baiyunshan (600332.SH) announced that its subsidiary Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for its drug supplement application, indicating progress in its product development and regulatory compliance [1]. Group 1 - The approved products include injectable Cefoperazone Sodium and Sulbactam Sodium in dosages of 1.0g, 1.5g, and 2.0g, as well as Clindamycin Phosphate Injection in dosages of 2ml: 0.3g and 4ml: 0.6g [1]. - The approved drugs have passed the consistency evaluation of generic drug quality and efficacy, which is a significant milestone for the company [1].